Investors are welcome to contact Charlotte Videbæk to learn more about plans and opportunities
Company Timeline
2024
- Tissue factor bound to CE labeled sponge in high density
- Medical device packaging system developed
- Grand Solutions grant awarded (DKK 8.3 million) Press Release
2023
- Strengthening of Board of Directors
- Positive preliminary 7 months stability data
- 2nd Innobooster SMV grant awarded (DKK 0.8 million)
2022
- EPO (European Patent Office) acknowledgment of patentability
- 2nd in-vivo positive results proof of efficacy and safety
- Manufacturing-friendly and stable cell line for tissue factor production transferred to cell bank
- Tissue factor bound to CE-labeled thin nano-cellulose dressing in high density
- Establishment cell line for recombinant tissue factor production
- In vitro activity assay established
2021
- MOA (Mode of Action) confirmed
- 1st Innobooster SMV grant awarded (DKK 0.8 million)
2020
- 1st in-vivo positive efficacy results in mini-pigs using dressings with bound tissue factor
- 1st patent application filed
- 1st ex vivo positive proof of concept
2019
- Tissue-Link ApS established